This study is a clinical trial that will be designed to evaluate the effect of flaxseed on anthropometric indices and androgen levels in women with polycystic ovary syndrome . In this study after obtaining written consent from people participating in the study , the information that are required will be collected by filling out the general information questionnaire. Inclusion criteria are Polycystic ovary syndrome, being overweight or obese and aged 20 to 40 years,Exclusion criteria are pregnancy and lactation, using of hormonal or steroid drugs , history of gastrointestinal obstruction, inflammatory bowel disease,using of anti-platelet drug, and being sensitive to flax seeds,to assess dietary intakes of food 3-day questionnaire will be used.In this study, subjects will be divided into two groups by Using a table of random numbers.The first group will undergo weight loss diet with a daily intake of 15 grams of flaxseed and the second group will undergo weight loss diet with a daily intake of 15 grams of bread powder. Flaxseed and dry bread powder will be packaged and coding in completely similar packet. Researchers and patients, are not aware of the type supplements in the packet. At the beginning and end of the intervention period, anthropometric measurements and serum total testosterone, free testosterone and sex hormone-binding protein will be measured.